Ropack Pharma Solutions Selects TraceLink to Achieve DSCSA Compliance for its Pharmaceutical Customers
North Reading, MA (January 25, 2017)—TraceLink Inc., the World’s Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced that Ropack Pharma Solutions has selected TraceLink to provide serialization solutions for its customers. Leveraging the TraceLink Life Sciences Cloud, Ropack’s international serialization hub provides an efficient and streamlined solution to assist its 130+ pharmaceutical manufacturing customers prepare for the rapidly approaching serialization deadline in November 2017 to comply with the U.S. Drug Supply Chain Security Act (DSCSA).
Ropack Pharma Solutions is a leading contract development and manufacturing organization (CDMO) that brings solid oral dosage packaging solutions to the top pharmaceutical and natural health organizations throughout Canada and the United States. The Ropack international serialization hub enables packaged pharmaceutical products to be sent by an organization’s in-house packaging team or contract partners to the Ropack facility. Using the TraceLink Life Sciences Cloud and Optel Vision, the packaged products are serialized, aggregated and then shipped with the appropriate complication documentation, to a distribution network or another warehouse.
“Serialization and regulatory compliance are complex process, but with TraceLink, it’s a simple connection that is low cost and managed entirely by their in-house experts. We selected TraceLink because it offers an easy-to-use platform that helps our customers achieve compliance without all the challenges and difficulties that pharmaceutical manufacturers often face when implementing a serialization program,” said Paul DuPont, Vice President of Marketing and Business Development, Ropack. “Becoming serialization ready for DSCSA is a complicated, time-consuming and costly endeavor for all companies, large and small. Our international serialization hub, leveraging the TraceLink Life Sciences Cloud as a core component, reduces an organization’s capital expenditures, need for increased personnel and the multifaceted coordination required for serialization.”
“Time is crucial with the first DSCSA serialization deadline going into effect later this year. Companies ultimately need to master the complex DSCSA requirements, implement their solution to generate, store and manage unprecedented volumes of regulated data, and exchange that data with all of their supply chain partners. Complying with serialization is a daunting task that takes time, money and resources, and for companies that haven’t started yet, being ready by November 2017 may be unattainable,” said Shabbir Dahod, president and CEO of TraceLink. “TraceLink lifts all of these burdensome tasks and partners with Ropack to offer an efficient and practical alternative to companies looking to outsource their serialization programs.”
With more than 500 life sciences customers and over 246,000 trading partners on the Life Sciences Cloud network, TraceLink provides an end-to-end compliance solution for the pharmaceutical supply chain. Customers integrate once and immediately interoperate with all of their trade partners to securely exchange regulatory data and cost-effectively comply with track and trace requirements.
To learn more about meeting global or country-specific pharmaceutical compliance deadlines and how to build a flexible serialization, track and trace, and reporting platform for the U.S., the EU, China, Brazil, South Korea, India, Turkey, Argentina and other countries, please visit www.tracelink.com.
About TraceLink
TraceLink is the World’s Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte’s Technology Fast 500 (ranked number 149 in 2016), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.
TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
About Ropack
Ropack, a contract manufacturing and packaging provider for the pharmaceutical and consumer health-care industries, offers turnkey primary and secondary packaging of tablets, capsules and powders into blisters, bottles, sachets, stick pack and vials. Ropack operates ambient and refrigerated warehousing space and provides temperature-controlled clinical distribution services for the Canadian market. Facilities are cGMP compliant; Health Canada certified and FDA licensed for Rx products, including controlled substances. Visit www.ropack.com or follow us on LinkedIn and Facebook.
The post PRESS RELEASE: Ropack appeared first on Dope Magazine.